Detalhe da pesquisa
1.
Post-Hyaluronic Acid Filler Reaction Treated With Abrocitinib: A Case Report.
J Drugs Dermatol
; 23(1): 1355-1356, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38206137
2.
Talquetamab-Induced Grover's Disease.
J Drugs Dermatol
; 22(8): 828-829, 2023 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37556510
3.
Rethinking the Inflammatory Balance in Psoriasis and Atherosclerosis.
J Drugs Dermatol
; 22(8): 832-834, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37556517
4.
Safety and efficacy of dual tyrosine kinase 2 inhibitor and monoclonal antibody therapy for psoriasis and psoriatic arthritis.
Br J Dermatol
; 190(3): 451-453, 2024 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38011328
5.
Use of dual biologic therapy targeting the Th2 and Th17 axes simultaneously to treat patients with atopic dermatitis and concomitant psoriasis, psoriatic arthritis, or inflammatory bowel disease.
J Am Acad Dermatol
; 2024 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38494153
6.
Characteristics, outcome, and response to therapy of multirefractory chronic immune thrombocytopenia.
Blood
; 128(12): 1625-30, 2016 09 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-27354722
7.
Risk of rebound psoriasis flare from systemic corticosteroid use in patients with psoriasis: A retrospective cohort study.
J Am Acad Dermatol
; 88(5): 1182-1183, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36538947
8.
Hamster Melatonin Receptors: Cloning and Binding Characterization of MT1 and Attempt to Clone MT2.
Int J Mol Sci
; 19(7)2018 Jul 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29973510
9.
Why Are We Still Cloning Melatonin Receptors? A Commentary.
Methods Mol Biol
; 2550: 267-281, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36180698
10.
Approach to the specificity and selectivity between D2 and D3 receptors by mutagenesis and binding experiments part I: Expression and characterization of D2 and D3 receptor mutants.
Protein Sci
; 31(12): e4459, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36177735
11.
Biochemistry, structure, and cellular internalization of a four nanobody-bearing Fc dimer.
Protein Sci
; 30(9): 1946-1957, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34117809
12.
Studies of the melatonin binding site location onto quinone reductase 2 by directed mutagenesis.
Arch Biochem Biophys
; 477(1): 12-9, 2008 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18502195
13.
Bexarotene use in refractory Darier's disease.
Int J Dermatol
; 62(11): e587-e589, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37381738
14.
Spesolimab use in treatment of pyoderma gangrenosum.
JAAD Case Rep
; 34: 18-22, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36936866
15.
Characterization of the Mel1c melatoninergic receptor in platypus (Ornithorhynchus anatinus).
PLoS One
; 13(3): e0191904, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29529033
16.
Gene expression profiling during hibernation in the European hamster.
Sci Rep
; 8(1): 13167, 2018 09 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30177816
17.
Cellular knock-down of quinone reductase 2: a laborious road to successful inhibition by RNA interference.
Biochimie
; 89(10): 1264-75, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17714848
18.
Cutaneous reaction reported after third Moderna COVID-19 vaccine.
JAAD Case Rep
; 18: 49-50, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34722839
19.
Update on human alpha1-adrenoceptor subtype signaling and genomic organization.
Trends Pharmacol Sci
; 25(9): 449-55, 2004 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-15559245
20.
Characterization of the melatoninergic MT3 binding site on the NRH:quinone oxidoreductase 2 enzyme.
Biochem Pharmacol
; 71(1-2): 74-88, 2005 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-16293234